Efficacy and Safety of Probiotics, Prebiotics and Synbiotics for the Treatment of Functional Constipation in

Cui Liang1,2, Xinxin Deng3, Hanbin Wang1,2

  • 1Health Technology Assessment Center/Evidence-Based Social Science Research Center, School of Public Health, Lanzhou University, Lanzhou, China.

PubMed

Insights

Probiotics, prebiotics, and synbiotics show potential for improving stool consistency and reducing abdominal pain in children with functional constipation. However, current evidence is limited, necessitating further research to confirm these benefits.

Area of Science:

  • Pediatric Gastroenterology
  • Microbiome Research
  • Clinical Nutrition

Background:

  • Functional constipation is a common pediatric issue.
  • Gut microorganisms, including probiotics, show promise in treatment.
  • Evidence on prebiotics and synbiotics for childhood constipation is evolving.

Purpose of the Study:

  • To evaluate the efficacy of probiotics, prebiotics, and synbiotics in treating functional constipation in children.
  • To compare different types of interventions using network meta-analysis.

Main Methods:

  • Comprehensive search of eight electronic databases up to July 2024.
  • Inclusion of randomized controlled trials (RCTs) on childhood functional constipation.
  • Network meta-analysis using a frequentist framework and Cochrane Risk of Bias tool.

Main Results:

  • Fifteen RCTs with 1087 participants were analyzed.
  • No significant difference in bowel movements per week compared to placebo.
  • Potential benefits for stool consistency (Mixed synbiotics, Lactulose) and abdominal pain (synbiotics) observed, but with very low to low certainty evidence.

Conclusions:

  • Prebiotics and synbiotics may offer benefits for stool consistency and abdominal pain in pediatric functional constipation.
  • Current evidence is of very low to low certainty.
  • Larger, well-designed RCTs are needed to validate these findings.

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
981
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives01:22

Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives

Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
651
Drugs Affecting GI Tract Motility: Other Laxatives01:20

Drugs Affecting GI Tract Motility: Other Laxatives

Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
1.2K
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
671
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.1K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
797